Fu et al. showed both the mRNA and protein levels of PTEN was decreased in CDDP-resistant ovarian cancer tissues (N=5) compared with CDDP-sensitive ovarian cancer tissues (N=5) 24. This evidence concerns the gene PTEN and ovarian carcinoma.